1. Home
  2. HTGC vs BHVN Comparison

HTGC vs BHVN Comparison

Compare HTGC & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hercules Capital Inc.

HTGC

Hercules Capital Inc.

N/A

Current Price

$16.94

Market Cap

3.2B

Sector

Finance

ML Signal

N/A

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

N/A

Current Price

$13.20

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HTGC
BHVN
Founded
2003
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.1B
IPO Year
2004
2022

Fundamental Metrics

Financial Performance
Metric
HTGC
BHVN
Price
$16.94
$13.20
Analyst Decision
Strong Buy
Buy
Analyst Count
9
17
Target Price
$19.50
★ $21.27
AVG Volume (30 Days)
1.1M
★ 2.7M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
★ 11.18%
N/A
EPS Growth
14.91
★ 26.08
EPS
★ 0.90
N/A
Revenue
N/A
N/A
Revenue This Year
$9.32
N/A
Revenue Next Year
$7.07
N/A
P/E Ratio
$18.86
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.70
$7.48
52 Week High
$19.13
$18.57

Technical Indicators

Market Signals
Indicator
HTGC
BHVN
Relative Strength Index (RSI) 38.79 47.35
Support Level $16.37 $8.43
Resistance Level $17.15 $14.01
Average True Range (ATR) 0.29 0.83
MACD -0.10 0.00
Stochastic Oscillator 9.77 50.16

Price Performance

Historical Comparison
HTGC
BHVN

About HTGC Hercules Capital Inc.

Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: